Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is an interventional new drug clinical trial for a Phase 2 randomized, double-blind, and placebo control study using intravenous injection of allogeneic adipose stem cells (Celltex AdMSCs) for subjects with severe COVID-19.
Epistemonikos ID: 758f81755ce6b704a06cd71b477324c91e2073fa
First added on: Aug 24, 2021